Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 14Head & Neck 5Genitourinary 4Lymphoid 3Endocrine 3CNS 3Sarcoma 2Other hematologic neoplasm 2Breast 2Plasma cell 1Other 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Multiple Endocrine Neoplasia Type 1 2Thyroid Cancer, Papillary 1Sexual Behavior 1Homosexuality 1Depression 1Alcoholism 1Alcohol Drinking 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Ethanol × Endocrine × Clear all
NCT03361384 2021-07-23

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

Syracuse University

Phase 1 Completed
260 enrolled
Endocrine

Alcohol Drinking, Homosexuality, Sexual Behavior, Multiple Endocrine Neoplasia Type 1

NCT01974284 2019-11-25

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Yale University

Phase NA Terminated
7 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡